Sean Lavin
Stock Analyst at BTIG
(1.93)
# 1,688
Out of 4,667 analysts
46
Total ratings
78.95%
Success rate
32.62%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $15.77 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $78.57 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $261.99 | +22.14% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $85.00 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $36.34 | +32.09% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $163.50 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.46 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $75.47 | +6.00% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $15.36 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $53.92 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $117.13 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.75 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $90.33 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $74.88 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $70.20 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.77
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $78.57
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $261.99
Upside: +22.14%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $85.00
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $36.34
Upside: +32.09%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $163.50
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.46
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $75.47
Upside: +6.00%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $15.36
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $53.92
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $117.13
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $1.75
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $90.33
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $74.88
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $70.20
Upside: -